Market Overview

Middlefield Healthcare & Life Sciences Dividend Fund Announces Normal Course Issuer Bid

Share:

Middlefield Healthcare & Life Sciences Dividend Fund Announces Normal Course Issuer Bid

Canada NewsWire

CALGARY, Aug.1, 2018 /CNW/ - Middlefield Healthcare & Life Sciences Dividend Fund announced that it has filed a notice with the Toronto Stock Exchange (the "TSX") and received its approval to make a normal course issuer bid ("NCIB"). Purchases pursuant to the NCIB will be made in the open market through the facilities of the TSX.  This NCIB will commence on August 4, 2018 and will terminate on August 3, 2019.  In accordance with the Declaration of Trust by which the Fund is governed, market purchases pursuant to its NCIB may be effected by the Fund.

The Fund had 9,295,600 units issued and outstanding as at July 25, 2018.  The Fund may, during the 12 month period commencing August 4, 2018 purchase on the TSX up to 919,360 units, being 10% of the public float and may not, in any 30 day period, purchase more than 185,912 units, being 2% of the units issued and outstanding.  The Fund will hold in treasury for resale all units purchased pursuant to the bid.  As at July 25, 2018 the Fund had purchased 1,012,800 units on the TSX at an average price of $9.66 per unit under its previously approved normal course issuer bid.  The Fund had the ability to purchase up to 1,016,000 units under its last NCIB. The manager of the Fund believes that such purchases are in the best interest of the Fund and are a desirable use of its available funds.

Middlefield Healthcare & Life Sciences Dividend Fund trades on the Toronto Stock Exchange under the symbol "LS.UN".

This press release may contain forward-looking information, including with respect to future purchases of Units by the Corporation.  The forward-looking information contained in this press release constitutes current expectations, as of the date of this press release, with respect to the matters covered hereby.  Investors and others should not assume that any forward-looking statement contained in this press release represents an estimate as of any date other than the date of this press release.

SOURCE Middlefield Healthcare & Life Sciences Dividend Fund

View original content: http://www.newswire.ca/en/releases/archive/August2018/01/c6669.html

View Comments and Join the Discussion!